DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Rajesh K. et al.
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.
Lancet 2007; 370: 1907-1914
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.